The global burden of cardiovascular disease

Journal of Cardiovascular Nursing

Volumn 26, Issue 4 SUPPL., 2011, Pages

  Deaton, Christi ^a   Froelicher, Erika Sivarajan ^b   Wu, Lai Har ^c   Ho, Camille ^d   Shishani, Kawkab ^e   Jaarsma, Tiny ^f  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^d Hong Kong Adventist Hospital   (Hong Kong)

^e WASHINGTON STATE UNIVERSITY   (United States)

^f LINKÖPING UNIVERSITY   (Sweden)

Author keywords

cardiovascular disease; developing countries; prevention

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; COST OF ILLNESS; HEALTH; HEALTH EDUCATION; HUMAN; INTERDISCIPLINARY COMMUNICATION; NURSE ATTITUDE; NURSING; NURSING DISCIPLINE; ORGANIZATION AND MANAGEMENT; PRIMARY PREVENTION; RISK FACTOR;

CARDIOVASCULAR DISEASES; COST OF ILLNESS; HEALTH EDUCATION; HUMANS; INTERDISCIPLINARY COMMUNICATION; NURSE'S ROLE; PRIMARY PREVENTION; RISK FACTORS; SPECIALTIES, NURSING; WORLD HEALTH;

EID: 79958844298     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/JCN.0b013e318213efcf     Document Type: Article

References (74)

1. Gaziano TA. Economic burden and the cost-effectiveness of treatment of cardiovascular disease in Africa. Heart. 2008;94(2):140-144. (Pubitemid 351211717)
2. World Health Organization, 2009. Cardiovascular Diseases. http://www.who.int/mediacentre/factsheets/fs317/en/index.html; http://www.who.int/cardiovascular-diseases/priorities/en/index.html. Accessed June 17, 2010.
3. World Health Organization, 2005. Preventing chronic diseases: a vital investment. http://www.who.int/chp/chronic- disease-report/contents/en/index. html. Accessed June 17, 2010.
4. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747-1757. (Pubitemid 43767064)
5. World Health Organization. Women and Health: Today's Evidence, Tomorrow's Agenda. Geneva, Switzerland: WHO Press; 2009. All rights reserved. Publications of the World Health Organization.
6. World Health Databook 2007/2008. London: Euromonitor International. London, UK: Euromonitor International Ltd; 2008.
7. Omran A. The epidemiologic transition: a theory of the epidemiology of population change. Milbank Q. 2005;83(4): 731-757. (Pubitemid 43127784)
8. Reprinted from Milbank Mem Fund Q. 1971; 49(4):509-538.
9. Yusuf S, Hawken S, Ounpuu S, et al; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004; 364(9438):937-952. (Pubitemid 39208455)
10. Drewnowski A, Popkin B. The nutrition transition: new trends in the global diet. Nutr Rev. 1997;55(2):31-43. (Pubitemid 27220092)
11. Alwan AA. Cardiovascular diseases in the eastern Mediterranean region. World Health Stat Q. 1993;46(2):97-100. (Pubitemid 24017908)
12. Muna WF. Cardiovascular disordersinAfrica. World Health Stat Q. 1993;46(2):125-133.
13. Reddy KS. Cardiovascular diseases in India. World Health Stat Q. 1993;46(2):101-107. (Pubitemid 24017909)
14. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation. 2001;104(23): 2855-2864. (Pubitemid 33126663)
15. Gupta R. Trends in hypertension epidemiology in India. J Hum Hypertens. 2004;18(2):73-78. (Pubitemid 38247814)
16. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases part I: general considerations, the epidemiologic transition, risk factors and impact of urbanization. Circulation. 2001;104(22):2746-2752.
17. World Health Organization. Health Topics: Risk Factors. 2010. http://www.who.int/topics/risk-factors/en/. Accessed June 17, 2010.
18. Kramer KM, Newton KM, Sivarajan Froelicher ES. Cardiovascular risk factors. In: Woods SL, Sivarajan Froelicher ES, Adams Motzer Underhill S, Bridges EJ, eds. Cardiac Nursing. 6th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2008:753-782.
19. Mackay J, Mensah GA. The Atlas of Heart Disease and Stroke. Geneva, Switzerland: World Health Organization; 2004.
20. Rosengren A, Subramanian SV, Islam S, et al; for the INTERHEART Investigators. Education and risk for acute myocardial infarction in 52 high, middle and low-income countries: INTERHEART case-control study. Heart. 2009;95(24):2014-2022.
21. Anand SS, Islam S Rosengren A, Franzosi MG, Steyn K, Yusufali AH, et al; on behalf of the INTERHEART Investigators. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J. 2008;29(7):932-940. (Pubitemid 351499478)
22. Kotseva K, Wood D, DeBacker G, DeBacquer D, Pyorala K, Keil U, for the EUROASPIRE Study Group. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet. 2009;373(9667):929-940.
23. Motlagh B, O'Donnell M, Yusuf S. Prevalence of cardiovascular risk factors in the Middle East: a systematic review. Eur J Cardiovasc Prev Rehabil. 2009;16(3):268-280.
24. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217- 223. (Pubitemid 40138015)
25. Gajalakshmi CK, Jha P, Ranson K, Nguyen S. Global patterns of smoking and smoking-attributable mortality. In: Jha P, Chaloupka F, eds. Tobacco Control in Developing Countries. OUP for World Bank and World Health Organization. http://www1.worldbank.org/tobacco/tcdc/009TO040. pdf. Accessed June 17, 2010.
26. World Health Organization. Water pipe tobacco smoking: health effects, research needs and recommended actions by regulations. The WHO Study Group on Tobacco Product Regulation. 2005. http://www.who.int/tobacco/global- interaction/tobreg/waterpipe/en/index.html.
27. Shihadeh A, Saleh R. Polycyclic aromatic hydrocarbons, carbon monoxide, "tar," and nicotine in the mainstream smoke aerosol of the narghile water pipe. Food Chem Toxicol. 2005;43(5):655-661. (Pubitemid 40381167)
28. Maziak W. Patterns of waterpipe use and dependence: implications for intervention development. Pharmacol Biochem Behav. 2005;80(1):173-179. (Pubitemid 40126215)
29. Maziak W. Prevalence and characteristics of narghile smoking among university students in Syria. Int J Tuberc Lung Dis. 2004;8(7):882-889. (Pubitemid 38937606)
30. Maziak W, Ward K, Soweid A, Eissenberg T. Tobacco smoking using a waterpipe: a re-emerging strain in a global epidemic. Tob Control. 2004;13(4):327-333. (Pubitemid 39635917)
31. Friel S, Chopra M, Satcher D. Unequal weight: equity oriented policy responses to the global obesity epidemic. BMJ. 2007;335:1241-1243.
32. Baker JL, Olsen LW, Sorenson TIA. Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med. 2007;357:2329-2337. (Pubitemid 350223387)
33. Bibbens-Domingo K, Coxson P, Pletcher MJ, Lightwood J, Goldman L. Adolescent overweight and future adult coronary heart disease. N Engl J Med. 2007;357:2371-2379. (Pubitemid 350244535)
34. Popkin BM. The nutrition transition in low-income countries: an emerging crisis. Nutr Rev. 1994;52(9):285-298. (Pubitemid 24336434)
35. World Health Organization. Preparation and Use of Food-Based Dietary Guidelines. WHO Technical Report, Series 880. Report of a Joint FAO/WHO Consultation. Geneva, Switzerland: World Health Organization; 1996.
36. Critchley J, Liu J, Zhao D, Wei W, Capewel S. Explaining the increase in coronary heart disease mortality in Beijing between 1984-1999. Circulation. 2004;110(10): 1236-1244. (Pubitemid 39202339)
37. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation. 1998;97(6): 596-601. (Pubitemid 28090690)
38. Rosamond WD, Chambless LE, Folsom AR, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med. 1998;339(13):861-867. (Pubitemid 28446843)
39. Sytkowski PA, D'Agostino RB, Belanger AK, Kannel WB. Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality. The Framingham Heart Study 1950 to 1990. Circulation. 1996;93(4):697-703. (Pubitemid 26052455)
40. Okrainec K, Benerjee D, Eisenberg M. Coronary artery disease in the developing world. Am Heart J. 2004;148(1):7-15. (Pubitemid 38900475)
41. Clarke R, Emberson J, Fletcher A, Breeze E, Marmot M, Shipley MJ. Life expectancy in relation to cardiovascular risk factors: 38 year follow-up of 19,000 men in the Whitehall study. BMJ. 2009;339:b3513.
42. Unal B, Critchley JA, Fidan D, Capewell S. Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000. Am J Public Health. 2005;95(1):103-108. (Pubitemid 40075890)
43. O'Flaherty M, Ford E, Allender S, Scarborough P, Capewell S. Coronary heart disease trends in England and Wales from 1984 to 2004; concealed leveling of mortality rates among young adults. Heart. 2007;94(2):178-181.
44. Capewell S, Morrison CE, McMurray JJ. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart. 1999;81(4):380-386. (Pubitemid 29167127)
45. Ford ES, Capewell S. Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol. 2007;50(22):2128-2132. (Pubitemid 350117339)
46. Gupta R, Misra A, Vikram NK, et al. Younger age of escalation of cardiovascular risk factors in Asian Indian subjects. BMC Cardiovasc Disord. 2009;9:28.
47. Liu Z. Dietary sodium and the incidence of hypertension in the Chinese population: a review of nationwide surveys. Am J Hypertens. 2009;22(9):929-933.
48. Kadiri S. Tackling cardiovascular disease in Africa. BMJ. 2005;331(7519):711-712. (Pubitemid 41414937)
49. Lopez AD, Mathers CD. Measuring the global burden of disease and epidemiological transitions: 2002-2030. Ann Trop Med Parasitol. 2006;100(5-6):481-499. (Pubitemid 47050869)
50. Murray CJ, Lopez AD. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability From Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard; 1996
51. World Health Organisation Global Infobase International Comparisons. https://apps.who.int/infobase/Comparisons. aspx. Accessed January 5, 2011.
52. Azambuja MI, Foppa M, Maranhao MF, Achutti AC. Economic burden of severe cardiovascular diseases in Brazil: an estimate based on secondary data. Arq Bras Cardiol. 2008;91(3):148-155.
53. Iestra J, Kromhout D, van der Schouw Y, Grobbee D, Boshuizen H, van Staveren W. Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Circulation. 2005;112(6):924-934. (Pubitemid 41170081)
54. Rose G. The Strategy of Preventive Medicine. Oxford: Oxford Medical Publications; 1994.
55. Tunstall-Pedow H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P; for the WHO MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) project. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet. 1999;353(9164):1547-1557. (Pubitemid 29219203)
56. Laatikainen T, Critchley J, Vartianinen E, Salomaa V, Ketonen M, Capewell S. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol. 2005;162(8):764-773. (Pubitemid 41437763)
57. European Society of Cardiology 2008. General Press Release: heart attack rates fall following smoking bans. http://www.escardio.org/about/press/press- releases/pr-08/pages/heart-attack-rates-fall.aspx. Accessed June 17, 2010.
58. Lawlor DA, Chaturvedi N. Treatment and prevention of obesityVare there critical periods for intervention? In J Epidemiol. 2006;35(1):3-9. (Pubitemid 43205431)
59. Watson R. Steps to a leaner Europe. Br Med J. 2007; 335(7632):1238.
60. Westley H. Thin living. Br Med J. 2007;335(7632):1236-1237.
61. Ebrahim S, Beswick A, Burke M, Davey Smith G. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev. 2006;4: CD001561.
62. Pyorala K. Cardiovascular risk prediction systems have to be adapted and updated to current national conditions. Eur J Cardiovasc Prev Rehabil. 2006;113(5):674-675. (Pubitemid 44454838)
63. Wood DA, Kotseva K. Should cardiovascular disease prevention be undertaken by doctors or policymakers and politicians? Dialogues Cardiovasc Med. 2009;14(2):83-98.
64. Graham I, Atar D, Borch-Johnsen K, et al. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur J Cardiovasc Prev Rehabil. 2007;14(suppl 2):E1-E40. (Pubitemid 47342420)
65. Mosca L, Banka CL, Benjamin EJ, et al. American Heart Association, American Academy of Family Physicians, American College of Obstetricians and Gynecologists, American College of Cardiology Foundation, Society of Thoracic Surgeons, American Medical Women's Association, Centers for Disease Control and Prevention, Office of Research on Women's Health, Association of Black Cardiologists, American College of Physicians, World Heart Federation, National Heart, Lung, and Blood Institute, American College of Nurse Practitioners. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation. 2007;115(11):1481-1501.
66. Fagard RH. Prescription and results of physical activity. J Cardiovasc Pharmacol. 1995;25(suppl 1):S20-S27.
67. Goldstein MG, Whitlock EP, DePue J. Planning Committee of the Addressing Multiple Behavioral Risk Factors in Primary Care Project. Multiple behavioral risk factor interventions in primary care. Summary of research evidence. Am J Prev Med. 2004;27(2 suppl):61-79.
68. Holme I, Haaheinm LL, Tonstad S, Hjermann I. Effect of dietary and antismoking advice on the incidence of myocardial infarction: a 16-year follow-up of the Oslo Diet and Antismoking Study after its close. Nutr Metab Cardiovasc Dis. 2006;16(5):330-388.
69. Berra K, Houston Miller N, Fair JM. Cardiovascular disease prevention and disease management: a critical role for nursing. J Cardiopulm Rehab. 2006;26(4):197-206. (Pubitemid 44641513)
70. Kamensky G, Murin J. Should cardiovascular disease prevention be undertaken by national cardiac societies? Dialogues Cardiovasc Med. 2009;14(2):1-6, 111.
71. The Catalonia Declaration investing in heart health. Declaration of the Advisory Board of the Second International Heart Health Conference; June 1, 1995; Barcelona, Catalonia, Spain. http://www.med.mun.ca/chhdbc/pdf/catalona. pdf. Accessed June 17, 2010.
72. The Victoria Declaration on heart health. Declaration of the Advisory Board of the International Heart Health Conference; May 28, 1992; Victoria, Canada. http://www. internationalhearthealth.org/Publications/victory-eng-1992. pdf. Accessed June 17, 2010.
73. New Zealand Guidelines Group (NZGG). Cardiac rehabilitation. 2002. http://www.nzgg.org.nz/guidelines/0001/cardiac-rehabilitation.pdf. Accessed June 17, 2010.
74. Pearson T, Blair S, Daniels S, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 update: census panel guide to comprehensive risk reduction for adult patient with coronary or other atherosclerotic vascular diseases. Circulation. 2002;106(3):388-391. http://www.circ. ahajournals.org/cgi/content/full/106/3/388. Accessed June 17, 2010. (Pubitemid 34778969)